Zhejiang Jiuzhou Pharmaceutical Co Ltd, based in Israel, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is ACYCLOVIR USP, with a corresponding US DMF Number 24934.
Remarkably, this DMF maintains an Active status since its submission on May 12, 2011, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of November 23, 2012, and payment made on November 13, 2012, indicating their dedication to facilitating drug approvals, Categorized as Type II